AI VIVO

AI Vivo is an early-stage Cambridge biotechnology company developing a generative AI system that constructs multi-scale biological models linking molecular targets through tissue and organ levels to whole-organism physiology.

Its technology integrates multi-modal omics data to simulate disease dynamics and treatment responses, aiming to replace conventional cell-based and animal models in early drug discovery and pharmacology.